Benign prostatic hyperplasia Trials in San Diego, United States
Conditions / Benign prostatic hyperplasia / San Diego, United States
Research into Benign prostatic hyperplasia spans multiple therapeutic approaches and trial phases.
13 total trials for this combination
Showing top 10 of 13 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02326454 | A Placebo Controlled Study of MR901 (Talaporfin Sodium Sodium + a Drug-activating Device) for the Relief of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia | COMPLETED | PHASE2 |
| NCT01939184 | Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia | COMPLETED | PHASE2 |
| NCT00848081 | A Study of Tadalafil in Men With Benign Prostatic Hyperplasia Symptoms Who Are Being Treated With Alpha Blockers | COMPLETED | PHASE3 |
| NCT02757768 | A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) | COMPLETED | PHASE4 |
| NCT00224133 | The Evaluation of the Safety of a New Drug for Benign Prostatic Hyperplasia Used for 9 Months | COMPLETED | PHASE3 |
| NCT01966614 | Randomized, Double-Blind, Vehicle-Controlled, Multicenter Safety and Efficacy Study of Intraprostatic PRX302 for LUTS BPH | COMPLETED | PHASE3 |
| NCT01097707 | A Study in Men With Benign Prostatic Hyperplasia | TERMINATED | PHASE2 |
| NCT00855582 | A Study in the Treatment of Erectile Dysfunction and Benign Prostate Hyperplasia | COMPLETED | PHASE3 |
| NCT00237536 | Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia | TERMINATED | PHASE2 |
| NCT01294150 | The Safety and Effectiveness of UroLift: LIFT Pivotal Study | COMPLETED | NA |